Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 153

1.

Efficacy and Long-Term Safety of H. pylori Eradication for Gastric Cancer Prevention.

Liou JM, Lee YC, El-Omar EM, Wu MS.

Cancers (Basel). 2019 Apr 28;11(5). pii: E593. doi: 10.3390/cancers11050593. Review.

2.

Calling time on formula milk adverts.

Godlee F, Cook S, Coombes R, El-Omar E, Brown N.

BMJ. 2019 Mar 17;364:l1200. doi: 10.1136/bmj.l1200. No abstract available.

PMID:
30880279
3.

Fecal microbiota transplantation confers beneficial metabolic effects of diet and exercise on diet-induced obese mice.

Lai ZL, Tseng CH, Ho HJ, Cheung CKY, Lin JY, Chen YJ, Cheng FC, Hsu YC, Lin JT, El-Omar EM, Wu CY.

Sci Rep. 2018 Oct 23;8(1):15625. doi: 10.1038/s41598-018-33893-y.

4.

Efficacies of Genotypic Resistance-Guided vs Empirical Therapy for Refractory Helicobacter pylori Infection.

Liou JM, Chen PY, Luo JC, Lee JY, Chen CC, Fang YJ, Yang TH, Chang CY, Bair MJ, Chen MJ, Hsu YC, Hsu WF, Chang CC, Lin JT, Shun CT, El-Omar EM, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium.

Gastroenterology. 2018 Oct;155(4):1109-1119. doi: 10.1053/j.gastro.2018.06.047. Epub 2018 Jun 30.

PMID:
29964036
5.

Adaptive response of neonatal sepsis-derived Group B Streptococcus to bilirubin.

Hansen R, Gibson S, De Paiva Alves E, Goddard M, MacLaren A, Karcher AM, Berry S, Collie-Duguid ESR, El-Omar E, Munro M, Hold GL.

Sci Rep. 2018 Apr 24;8(1):6470. doi: 10.1038/s41598-018-24811-3.

6.

Multi-omics differentially classify disease state and treatment outcome in pediatric Crohn's disease.

Douglas GM, Hansen R, Jones CMA, Dunn KA, Comeau AM, Bielawski JP, Tayler R, El-Omar EM, Russell RK, Hold GL, Langille MGI, Van Limbergen J.

Microbiome. 2018 Jan 15;6(1):13. doi: 10.1186/s40168-018-0398-3.

7.

Molecular Predictors of Gastric Neoplastic Progression.

Lochhead P, El-Omar EM.

Cancer Cell. 2018 Jan 8;33(1):9-11. doi: 10.1016/j.ccell.2017.12.006.

8.

Primary antibiotic resistance in Helicobacter pylori in the Asia-Pacific region: a systematic review and meta-analysis.

Kuo YT, Liou JM, El-Omar EM, Wu JY, Leow AHR, Goh KL, Das R, Lu H, Lin JT, Tu YK, Yamaoka Y, Wu MS; Asian Pacific Alliance on Helicobacter and Microbiota.

Lancet Gastroenterol Hepatol. 2017 Oct;2(10):707-715. doi: 10.1016/S2468-1253(17)30219-4. Epub 2017 Aug 7. Review.

PMID:
28781119
9.

Gastric Cancer as Preventable Disease.

Rugge M, Genta RM, Di Mario F, El-Omar EM, El-Serag HB, Fassan M, Hunt RH, Kuipers EJ, Malfertheiner P, Sugano K, Graham DY.

Clin Gastroenterol Hepatol. 2017 Dec;15(12):1833-1843. doi: 10.1016/j.cgh.2017.05.023. Epub 2017 May 19. Review.

PMID:
28532700
10.

Not All Mice Are the Same: Standardization of Animal Research Data Presentation.

Omary MB, Cohen DE, El-Omar EM, Jalan R, Low MJ, Nathanson MH, Peek RM Jr, Turner JR.

Cell Mol Gastroenterol Hepatol. 2016 May 6;2(4):391-393. doi: 10.1016/j.jcmgh.2016.04.001. eCollection 2016 Jul. No abstract available.

11.

Extending colonic mucosal microbiome analysis-assessment of colonic lavage as a proxy for endoscopic colonic biopsies.

Watt E, Gemmell MR, Berry S, Glaire M, Farquharson F, Louis P, Murray GI, El-Omar E, Hold GL.

Microbiome. 2016 Nov 25;4(1):61.

12.

Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Malfertheiner P, Megraud F, O'Morain CA, Gisbert JP, Kuipers EJ, Axon AT, Bazzoli F, Gasbarrini A, Atherton J, Graham DY, Hunt R, Moayyedi P, Rokkas T, Rugge M, Selgrad M, Suerbaum S, Sugano K, El-Omar EM; European Helicobacter and Microbiota Study Group and Consensus panel.

Gut. 2017 Jan;66(1):6-30. doi: 10.1136/gutjnl-2016-312288. Epub 2016 Oct 5.

PMID:
27707777
13.

Concomitant, bismuth quadruple, and 14-day triple therapy in the first-line treatment of Helicobacter pylori: a multicentre, open-label, randomised trial.

Liou JM, Fang YJ, Chen CC, Bair MJ, Chang CY, Lee YC, Chen MJ, Chen CC, Tseng CH, Hsu YC, Lee JY, Yang TH, Luo JC, Chang CC, Chen CY, Chen PY, Shun CT, Hsu WF, Hu WH, Chen YN, Sheu BS, Lin JT, Wu JY, El-Omar EM, Wu MS; Taiwan Gastrointestinal Disease and Helicobacter Consortium.

Lancet. 2016 Nov 12;388(10058):2355-2365. doi: 10.1016/S0140-6736(16)31409-X. Epub 2016 Oct 18.

PMID:
27769562
14.

Transporters for Antiretroviral Drugs in Colorectal CD4+ T Cells and Circulating α4β7 Integrin CD4+ T Cells: Implications for HIV Microbicides.

Mukhopadhya I, Murray GI, Duncan L, Yuecel R, Shattock R, Kelly C, Iannelli F, Pozzi G, El-Omar EM, Hold GL, Hijazi K.

Mol Pharm. 2016 Sep 6;13(9):3334-40. doi: 10.1021/acs.molpharmaceut.6b00351. Epub 2016 Aug 11.

PMID:
27467446
15.

Not all mice are the same: Standardization of animal research data presentation.

Omary MB, Cohen DE, El-Omar EM, Jalan R, Low MJ, Nathanson MH, Peek RM Jr, Turner JR.

Hepatology. 2016 Jun;63(6):1752-4. doi: 10.1002/hep.28608. No abstract available.

PMID:
27205897
16.

Not All Mice Are the Same: Standardization of Animal Research Data Presentation.

Omary MB, Cohen DE, El-Omar E, Jalan R, Low M, Nathanson M, Peek R, Turner J.

Gut. 2016 Jun;65(6):894-5. doi: 10.1136/gutjnl-2016-312041. No abstract available.

PMID:
27197119
17.

Not All Mice Are the Same: Standardization of Animal Research Data Presentation.

Omary MB, Cohen DE, El-Omar EM, Jalan R, Low MJ, Nathanson MH, Peek RM Jr, Turner JR.

Gastroenterology. 2016 Jun;150(7):1503-1504. doi: 10.1053/j.gastro.2016.03.034. Epub 2016 Apr 8. No abstract available.

PMID:
27063865
18.

Drug transporter gene expression in human colorectal tissue and cell lines: modulation with antiretrovirals for microbicide optimization.

Mukhopadhya I, Murray GI, Berry S, Thomson J, Frank B, Gwozdz G, Ekeruche-Makinde J, Shattock R, Kelly C, Iannelli F, Pozzi G, El-Omar EM, Hold GL, Hijazi K.

J Antimicrob Chemother. 2016 Feb;71(2):372-86. doi: 10.1093/jac/dkv335. Epub 2015 Oct 29.

PMID:
26514157
19.

The stomach in health and disease.

Hunt RH, Camilleri M, Crowe SE, El-Omar EM, Fox JG, Kuipers EJ, Malfertheiner P, McColl KE, Pritchard DM, Rugge M, Sonnenberg A, Sugano K, Tack J.

Gut. 2015 Oct;64(10):1650-68. doi: 10.1136/gutjnl-2014-307595. Epub 2015 Sep 4. Review.

20.

Kyoto global consensus report on Helicobacter pylori gastritis.

Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, Haruma K, Asaka M, Uemura N, Malfertheiner P; faculty members of Kyoto Global Consensus Conference.

Gut. 2015 Sep;64(9):1353-67. doi: 10.1136/gutjnl-2015-309252. Epub 2015 Jul 17. Review.

21.

Interplay of the Gastric Pathogen Helicobacter pylori with Toll-Like Receptors.

Pachathundikandi SK, Lind J, Tegtmeyer N, El-Omar EM, Backert S.

Biomed Res Int. 2015;2015:192420. doi: 10.1155/2015/192420. Epub 2015 Apr 6. Review.

22.

A multi-journal partnership to highlight joint first-authors of manuscripts.

Omary MB, Wallace MB, El-Omar EM, Jalan R, Nathanson MH.

Gastrointest Endosc. 2015 Feb;81(2):437-8. doi: 10.1016/j.gie.2014.12.006. No abstract available.

PMID:
25616757
23.

A multi-journal partnership to highlight joint first-authors of manuscripts.

Omary MB, Wallace MB, El-Omar EM, Jalan R, Nathanson MH.

Gastroenterology. 2015 Feb;148(2):274-5. doi: 10.1053/j.gastro.2014.11.001. No abstract available.

PMID:
25616684
24.

A multi-journal partnership to highlight joint first-authors of manuscripts.

Omary MB, Wallace MB, El-Omar EM, Jalan R, Nathanson MH.

J Hepatol. 2015 Feb;62(2):255-6. doi: 10.1016/j.jhep.2014.11.022. No abstract available.

25.

A multi-journal partnership to highlight joint first-authors of manuscripts.

Omary MB, Wallace MB, El-Omar EM, Jalan R, Nathanson MH.

Gut. 2015 Feb;64(2):189. doi: 10.1136/gutjnl-2014-308880. No abstract available.

PMID:
25573911
26.

The fungal microbiota of de-novo paediatric inflammatory bowel disease.

Mukhopadhya I, Hansen R, Meharg C, Thomson JM, Russell RK, Berry SH, El-Omar EM, Hold GL.

Microbes Infect. 2015 Apr;17(4):304-10. doi: 10.1016/j.micinf.2014.12.001. Epub 2014 Dec 15.

27.

A multi-journal partnership to highlight joint first-authors of manuscripts.

Omary MB, Wallace MB, El-Omar EM, Jalan R, Nathanson MH.

Hepatology. 2015 Feb;61(2):416-7. doi: 10.1002/hep.27631. No abstract available.

PMID:
25476851
28.

The TLR4 D299G and T399I SNPs are constitutively active to up-regulate expression of Trif-dependent genes.

Hold GL, Berry S, Saunders KA, Drew J, Mayer C, Brookes H, Gay NJ, El-Omar EM, Bryant CE.

PLoS One. 2014 Nov 3;9(11):e111460. doi: 10.1371/journal.pone.0111460. eCollection 2014.

29.

Cytokine gene polymorphisms, cytokine levels and the risk of colorectal neoplasia in a screened population of Northeast Scotland.

Basavaraju U, Shebl FM, Palmer AJ, Berry S, Hold GL, El-Omar EM, Rabkin CS.

Eur J Cancer Prev. 2015 Jul;24(4):296-304. doi: 10.1097/CEJ.0000000000000087.

30.

Two-stage genome-wide methylation profiling in childhood-onset Crohn's Disease implicates epigenetic alterations at the VMP1/MIR21 and HLA loci.

Adams AT, Kennedy NA, Hansen R, Ventham NT, OʼLeary KR, Drummond HE, Noble CL, El-Omar E, Russell RK, Wilson DC, Nimmo ER, Hold GL, Satsangi J.

Inflamm Bowel Dis. 2014 Oct;20(10):1784-93. doi: 10.1097/MIB.0000000000000179.

31.

Genetics of gastric cancer.

McLean MH, El-Omar EM.

Nat Rev Gastroenterol Hepatol. 2014 Nov;11(11):664-74. doi: 10.1038/nrgastro.2014.143. Epub 2014 Aug 19. Review.

PMID:
25134511
32.

MicroRNAs in gastrointestinal malignancy: a tool in cancer prevention?

Mactier KE, Glaire MA, Basavaraju U, El-Omar EM, Hold GL.

Eur J Cancer Prev. 2014 Nov;23(6):540-9. doi: 10.1097/CEJ.0000000000000014. Review.

PMID:
24608603
33.

Role of the gut microbiota in inflammatory bowel disease pathogenesis: what have we learnt in the past 10 years?

Hold GL, Smith M, Grange C, Watt ER, El-Omar EM, Mukhopadhya I.

World J Gastroenterol. 2014 Feb 7;20(5):1192-210. doi: 10.3748/wjg.v20.i5.1192. Review.

34.

Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment.

Kostic AD, Chun E, Robertson L, Glickman JN, Gallini CA, Michaud M, Clancy TE, Chung DC, Lochhead P, Hold GL, El-Omar EM, Brenner D, Fuchs CS, Meyerson M, Garrett WS.

Cell Host Microbe. 2013 Aug 14;14(2):207-15. doi: 10.1016/j.chom.2013.07.007.

35.

Update from EIC 2013.

El-Omar E.

Gut. 2013 Sep;62(9):1233. doi: 10.1136/gutjnl-2013-305727. No abstract available.

PMID:
23917537
36.

Expression of neutrophil gelatinase-associated lipocalin in colorectal neoplastic progression: a marker of malignant potential?

McLean MH, Thomson AJ, Murray GI, Fyfe N, Hold GL, El-Omar EM.

Br J Cancer. 2013 Jun 25;108(12):2537-41. doi: 10.1038/bjc.2013.264. Epub 2013 Jun 4.

37.

Helicobacter pylori susceptibility in the GWAS era.

El-Omar EM.

JAMA. 2013 May 8;309(18):1939-40. doi: 10.1001/jama.2013.5590. No abstract available.

PMID:
23652526
38.

The microaerophilic microbiota of de-novo paediatric inflammatory bowel disease: the BISCUIT study.

Hansen R, Berry SH, Mukhopadhya I, Thomson JM, Saunders KA, Nicholl CE, Bisset WM, Loganathan S, Mahdi G, Kastner-Cole D, Barclay AR, Bishop J, Flynn DM, McGrogan P, Russell RK, El-Omar EM, Hold GL.

PLoS One. 2013;8(3):e58825. doi: 10.1371/journal.pone.0058825. Epub 2013 Mar 12.

39.

Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn's Disease.

Rice SA, Woo PN, El-Omar E, Keenan RA, Ormerod AD.

BMC Res Notes. 2013 Jan 18;6:19. doi: 10.1186/1756-0500-6-19.

40.

Iron deficiency and Helicobacter pylori-induced gastric cancer: too little, too bad.

El-Omar EM.

J Clin Invest. 2013 Jan;123(1):113-4. doi: 10.1172/JCI67200. Epub 2012 Dec 21.

41.

Revision of the Atlanta classification of acute pancreatitis: the editorial perspective.

Gress TM, El-Omar EM; editorial board of Gut.

Gut. 2013 Jan;62(1):1. doi: 10.1136/gutjnl-2012-304051. No abstract available.

PMID:
23220947
42.

Microbiota of de-novo pediatric IBD: increased Faecalibacterium prausnitzii and reduced bacterial diversity in Crohn's but not in ulcerative colitis.

Hansen R, Russell RK, Reiff C, Louis P, McIntosh F, Berry SH, Mukhopadhya I, Bisset WM, Barclay AR, Bishop J, Flynn DM, McGrogan P, Loganathan S, Mahdi G, Flint HJ, El-Omar EM, Hold GL.

Am J Gastroenterol. 2012 Dec;107(12):1913-22. doi: 10.1038/ajg.2012.335. Epub 2012 Oct 9.

PMID:
23044767
43.

Genetics of Barrett's: the bigger, the better.

El-Omar EM, Jankowski J.

Am J Gastroenterol. 2012 Sep;107(9):1342-5. doi: 10.1038/ajg.2012.144.

PMID:
22951876
44.

The mesenchyme in malignancy: a partner in the initiation, progression and dissemination of cancer.

Glaire MA, El-Omar EM, Wang TC, Worthley DL.

Pharmacol Ther. 2012 Nov;136(2):131-41. doi: 10.1016/j.pharmthera.2012.08.007. Epub 2012 Aug 17. Review.

PMID:
22921882
45.

Lack of association between the rs2294008 polymorphism in the prostate stem cell antigen gene and colorectal neoplasia: a case-control and immunohistochemical study.

Smith C, Lochhead P, Basavaraju U, Hold GL, Fyfe N, Murray GI, El-Omar EM.

BMC Res Notes. 2012 Jul 23;5:371. doi: 10.1186/1756-0500-5-371.

46.

Genetic variation in C20orf54, PLCE1 and MUC1 and the risk of upper gastrointestinal cancers in Caucasian populations.

Palmer AJ, Lochhead P, Hold GL, Rabkin CS, Chow WH, Lissowska J, Vaughan TL, Berry S, Gammon M, Risch H, El-Omar EM.

Eur J Cancer Prev. 2012 Nov;21(6):541-4.

47.

Programmed chemotherapy for patients with metastatic unresectable gastric cancer.

Shinoda M, Ando T, El-Omar EM, Takashi H, Suzuki T, Murayama M, Morise K, Goto H.

PLoS One. 2012;7(6):e38652. doi: 10.1371/journal.pone.0038652. Epub 2012 Jun 26.

48.

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report.

Malfertheiner P, Megraud F, O'Morain CA, Atherton J, Axon AT, Bazzoli F, Gensini GF, Gisbert JP, Graham DY, Rokkas T, El-Omar EM, Kuipers EJ; European Helicobacter Study Group.

Gut. 2012 May;61(5):646-64. doi: 10.1136/gutjnl-2012-302084.

PMID:
22491499
49.

IBD-what role do Proteobacteria play?

Mukhopadhya I, Hansen R, El-Omar EM, Hold GL.

Nat Rev Gastroenterol Hepatol. 2012 Feb 21;9(4):219-30. doi: 10.1038/nrgastro.2012.14. Review.

PMID:
22349170
50.

Vacuolating cytotoxin and variants in Atg16L1 that disrupt autophagy promote Helicobacter pylori infection in humans.

Raju D, Hussey S, Ang M, Terebiznik MR, Sibony M, Galindo-Mata E, Gupta V, Blanke SR, Delgado A, Romero-Gallo J, Ramjeet MS, Mascarenhas H, Peek RM, Correa P, Streutker C, Hold G, Kunstmann E, Yoshimori T, Silverberg MS, Girardin SE, Philpott DJ, El Omar E, Jones NL.

Gastroenterology. 2012 May;142(5):1160-71. doi: 10.1053/j.gastro.2012.01.043. Epub 2012 Feb 11.

Supplemental Content

Loading ...
Support Center